HIV Diagnostics Market Size By Test Type (Antibody Test, Viral Load Test, CD4 Test), By End-use (Diagnostic Laboratories, Hospitals & Clinics, Home Settings), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Jul 2021  |  Report ID: GMI491  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 150   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry trends

HIV Diagnostics Market size exceeded USD 749 million in 2020 and is anticipated to witness over 0.4% CAGR from 2021 to 2027. In the last 30 years, there have been significant advances in the field of HIV diagnostics including enhancements in the test sensitivity for acute or early HIV detection, thus proving beneficial for the market growth. In addition, rising awareness and availability of improved HIV diagnostic kits especially in the developing economies will accelerate the market demand. Numerous market players such as Abbott and Chembio Diagnostics among others are focusing on developing advanced self-testing kits. However, reducing number of HIV cases in developed countries is a crucial factor that will reduce the usage for HIV diagnostics in the near future.
 

HIV Diagnostics Market Overview

Get more details on this report - Request Free Sample PDF
 

The impact of COVID-19 on HIV diagnostics market is observed to be substantial. Many parts of the world adopted lockdown to curb community transmission of the COVID-19 virus. This crucial move resulted in a substantial decline in the count of HIV diagnostic procedures and treatment visits in hospitals and other clinics, impacting the industry growth negatively.
 

Human immunodeficiency virus (HIV) attacks the body's immune system. Individuals suffering with HIV can get antiretroviral therapy and remain healthy for many years. Availability of different HIV diagnostic tests in the industry will foster the industry demand.
 

Growing prevalence of HIV in low- and middle-income countries will boost the market expansion

The burden of HIV is on the rise in developing countries, and HIV diagnostic tests play a vital role in the accurate diagnosis and treatment of an individual’s health. HIV remains a persistent problem for many African countries as well as other underdeveloped countries across the globe. Therefore, increasing burden of HIV in these countries will impel the demand for HIV diagnostics. However, low degree of penetration in the underdeveloped region may restrict the market to a certain extent.
 

Higher preference of antibody test will fuel the HIV diagnostics market value

The antibody test segment is projected to register 1.3% growth rate through 2027. Antibodies are produced by the immune system once exposed to the viruses including HIV, and these tests specifically look for HIV antibodies in saliva or blood. These tests can take nearly three to twelve weeks to detect the HIV infection after a contact thereby, proving beneficial for the overall industry expansion. Several rapid tests including FDA approved HIV self-test done at home, are antibody tests that surges the industry progression for antibody test.
 

Well-trained staff in hospitals propels the market revenue

HIV Diagnostics Market Size

Get more details on this report - Request Free Sample PDF

 

The hospitals & clinics segment in the HIV diagnostics market accounted for USD 285 million in 2020. Higher demand for accurate HIV diagnosis in the hospital settings will influence the industry growth. Similarly, surging necessity for appropriate patient care and management with the presence of experienced healthcare authorities in hospitals and clinics will stimulate the industry size.
 

Higher prevalence of HIV in African region will enhance the market progression

Africa HIV Diagnostics Market

Get more details on this report - Request Free Sample PDF

 

Africa HIV diagnostics market captured over 35.6% of revenue share in 2020. High incidence of HIV in the African countries, growing awareness regarding HIV diagnostics and testing procedures, and presence of numerous market participants in this region, are few of the aspects proving advantageous for the overall market growth. Moreover, beneficial initiatives by government and NGOs, and rising number of research partnerships will further drive the market expansion.
 

Ongoing innovation by leading companies have helped them capture larger market share

Some of the prominent players operating in the HIV diagnostics market include OraSure Technologies, Chembio Diagnostics, Abbott Laboratories, Cepheid, BD, BIONEER CORPORATION, Omega Diagnostics, Roche, Qiagen and Biomerieux among others. These industry leaders are implementing various growth strategies to sustain the market competition.
 

Some of the recent industry developments:

  • In December 2020, Atomo Diagnostic signed an agreement with PrEP Health Pty Ltd. for the distribution of HIV self-test. This strategic move helped the company to strengthen their business & HIV Diagnostics product portfolio.
     
  • In November 2020, Hologic Inc. received the U.S. FDA approval for HIV-1 viral load monitoring assay. This assisted the company to strengthen its HIV diagnostics product portfolio.
     

The HIV diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Test Type, 2016-2027 (USD Million)

  • Antibody Test
  • Viral load test
  • CD4 test

Market, By End-use, 2016-2027 (USD Million)

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Home Settings
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Russia
    • France
    • Spain
    • Italy
    • UK
    • Germany
  • Asia Pacific
    • India
    • China
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East
    • Iran
    • Saudi Arabia
    • Yemen
  • Africa
    • South Africa
    • Mozambique
    • Nigeria
    • United Republic of Tanzania
    • Kenya
    • Uganda
       

Frequently Asked Questions (FAQ) :

Market size of HIV diagnostics had surpassed USD 749 million in 2020 and will observe a CAGR of over 0.4% through 2027.
Antibody test segment will witness a CAGR of 1.3% through 2027 as this test specifically looks for HIV antibodies in saliva or blood and produces accurate results in less time.
Hospitals & clinics segment had accounted for USD 285 million in 2020 on account of increasing demand for accurate HIV diagnosis in hospital settings.
The regional market had held over 35.6% share in 2020 due to increasing demand driven by higher incidences of HIV, growing awareness about the disease and testing procedures in the country.

Premium Report Details

  • Published Date: Jul 2021
  • Pages: 150
  • Tables: 148
  • Charts / Figures: 11
  • Companies covered: 10
  • Countries covered: 22

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X